Hydroxychloroquine in a G6PD-Deficient Patient with COVID-19 Complicated by Haemolytic Anaemia: Culprit or Innocent Bystander?

Hydroxychloroquine has been used worldwide as a first-line treatment for patients hospitalized with COVID-19. Little is known about COVID-19 and its effects on patients with congenital red blood cell disorders. We report a case of haemolytic anaemia in a 32-year-old patient and a fortuitous highligh...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Eur J Case Rep Intern Med
Asıl Yazarlar: Mastroianni, François, Colombie, Vincent, Claes, Geraldine, Gilles, Axelle, Vandergheynst, Frédéric, Place, Sammy
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: SMC Media Srl 2020
Konular:
Articles
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7473690/
https://ncbi.nlm.nih.gov/pubmed/32908842
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12890/2020_001875
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller